PureTech Health PLC (STU:0VQ)
€ 1.81 -0.03 (-1.63%) Market Cap: 451.44 Mil Enterprise Value: 8.59 Mil PE Ratio: 0 PB Ratio: 1.51 GF Score: 47/100

PureTech Health PLC Medical Research Update Transcript

Dec 07, 2022 / 01:00PM GMT
Release Date Price: €3.32
Operator

Good day, and thank you for standing by. Welcome to the Vor Bio VBP101 Clinical Data Update Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to hand the conference over to Dr. Robert Ang, President and CEO of Vor Bio. Please go ahead.

Robert Ang
Vor Biopharma Inc. - President, CEO & Director

Thank you for joining our presentation, which we are proud to present the first clinical data from our clinical trial study patients with acute myeloid leukemia. I will point you to a disclaimer slide that you'll be able to read at your leisure on our website.

We will kick off with our founder, Siddhartha Mukherjee, who will be telling you a bit about how Vor was founded. We'll then be joined by Eyal Attar, who is our Chief Medical Officer, who will provide an overview of the VBP101 clinical trial. And the results will be presented by an investigator Brenda Cooper, who will be talking through results of our very first patients treated with VOR33, also known as trem-cel. We will

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot